Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics.
about
Homocysteine and cognitive impairment; a case series in a General Practice settingStructural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future PerspectivesAtrophy rates accelerate in amnestic mild cognitive impairment.New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.White matter disease as a biomarker for long-term cerebrovascular disease and dementia.Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline dataAutomatic Detection of White Matter Hyperintensities in Healthy Aging and Pathology Using Magnetic Resonance Imaging: A Review.White matter hyperintensities, cognitive impairment and dementia: an update.Is type 2 diabetes related to leukoaraiosis? an updated review.Longitudinal change of small-vessel disease-related brain abnormalitiesWhat are white matter hyperintensities made of? Relevance to vascular cognitive impairment.Current concepts of analysis of cerebral white matter hyperintensities on magnetic resonance imaging.Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imaging.Neuroimaging of white matter in aging and dementia.Cerebral atrophy in cerebrovascular disorders.Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.Outcome markers for clinical trials in cerebral amyloid angiopathy.Evaluation of apparent diffusion coefficient mappings in amnestic mild cognitive impairment using an image analysis software brain search.Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trialSimple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy.Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathyVitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patientsAge-related white matter changesAssociation between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients.Plasma tPA-Activity and Progression of Cerebral White Matter Hyperintensities in Lacunar Stroke Patients.Voxel based analyses of diffusion tensor imaging in Fabry disease.Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke.A priori collaboration in population imaging: The Uniform Neuro-Imaging of Virchow-Robin Spaces Enlargement consortiumWhite matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adultsBrain MRI abnormalities in the adult form of myotonic dystrophy type 1: A longitudinal case series studyBlood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease.White matter hyperintensities segmentation: a new semi-automated methodSetting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study.White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): rationale, design,Brain MR Imaging Findings of Cardiac-Type Fabry Disease with an IVS4+919G>A Mutation.Metric to quantify white matter damage on brain magnetic resonance images.White matter hyperintensity reduction and outcomes after minor stroke.
P2860
Q25257672-5D72B973-23D0-4F95-BC03-ED27B0999499Q28077809-366A4896-D7B4-4F83-8867-D2A61582998FQ30489846-99AB9CB8-3292-4F61-AC9C-C03907EDDC70Q30494800-5C60D66D-675E-44F9-A51F-3968EF9E0D96Q30655992-9EC669E6-3D6A-4CAE-A122-13240104A342Q30748716-4702D994-06C6-41C5-AB7B-2C24B85562CCQ30811136-83134CF4-B805-4752-83DB-6E293A389832Q30887442-D8BCE4CF-F0D3-4A8F-A453-C98FD7A9DFDEQ30893715-7A699EF7-FCFD-440E-8E28-B06CE0CE0416Q30910261-DCDD8B87-71A2-45F3-9D4C-964DD8DBCC39Q30938195-9028827B-106B-4235-90DD-E6C3C7999E68Q30976213-B0DF0D06-CECF-4FCF-9A91-336D0401DBA3Q31074248-2166376D-110E-4352-B7EA-AF706FC4F90CQ31107223-7FA795B6-C61B-4933-97CE-01540FE2BD0BQ33279055-AE48DA14-F6A9-42B9-B9E2-75EBB6090B3DQ33426571-0EF25F05-2875-4BB6-ACD8-36E45C241E05Q33576727-15240160-C7C2-4576-B8F8-88B5550E92F2Q33859442-0A706A70-439F-4B3E-AAD1-B047A6B8C2B8Q34039395-C29F2CE0-F308-4CFB-824A-6524D55DE4B6Q34439105-33E42E61-40C2-4CB9-A583-5CD2CF708550Q34568598-2002533D-11D9-40C8-B4AC-FE9850A33065Q34632746-35B071EB-5C84-4465-9642-4CA01D364007Q34770690-6C3ED65F-0C5E-4B84-81E0-99A4D3C0A570Q35025553-DDD40E2F-1613-478F-BB59-DF09E35A52F4Q35184834-E231AE03-6AAA-4D60-A151-7A52ED4A5E53Q35767680-D28AA613-87BD-4EFF-B127-8F9B505B8820Q35945812-5E7697B7-F773-479C-B7C9-4B6EF13BAB7CQ36227485-A71595AC-D5E8-46F7-9C68-F58C434D06CCQ36467304-8689B4F7-1749-4F16-A64A-5F74F47B1D87Q36933713-CF504022-80BD-44C5-B81B-9EF796223111Q37150711-A1FF6176-6F4B-454D-9866-F795A0B44049Q37161897-BCE1DF59-90A2-4CA2-8402-77402C10B96EQ37349706-E263E8E0-A861-4605-A28F-4559A295F067Q37379140-B103A7D4-A7D2-4069-8723-78DC147A43F8Q37603426-933426E4-80BB-4119-9B23-AC617B55641BQ37664085-296E3D1C-3A77-4858-802D-46CB303F48D3Q39389127-D476EB1B-986F-44FE-BF41-EBE9E112B58DQ40002919-23505B5C-FEA7-4007-A8A9-31F4E9036810Q40080510-D59D45D0-F6B1-4853-8B5F-C9D22D9A47C1Q40088554-2687DCBB-2AB4-49FF-880B-84ECD92880F5
P2860
Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Measuring progression of cereb ...... visual rating and volumetrics.
@en
Measuring progression of cereb ...... visual rating and volumetrics.
@nl
type
label
Measuring progression of cereb ...... visual rating and volumetrics.
@en
Measuring progression of cereb ...... visual rating and volumetrics.
@nl
prefLabel
Measuring progression of cereb ...... visual rating and volumetrics.
@en
Measuring progression of cereb ...... visual rating and volumetrics.
@nl
P2093
P1433
P1476
Measuring progression of cereb ...... visual rating and volumetrics.
@en
P2093
Koudstaal PJ
Scheltens P
Vrooman HA
van Dijk EJ
van Schijndel RA
van Straaten EC
P304
P356
10.1212/01.WNL.0000123264.40498.B6
P407
P577
2004-05-01T00:00:00Z